These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 33019399

  • 1. Clinical value of circulating tumor cells for the diagnosis and prognosis of hepatocellular carcinoma (HCC): A systematic review and meta-analysis.
    Cui K, Ou Y, Shen Y, Li S, Sun Z.
    Medicine (Baltimore); 2020 Oct 02; 99(40):e22242. PubMed ID: 33019399
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, Tomlinson JS, Tseng HR, Agopian VG.
    Liver Transpl; 2018 Jul 02; 24(7):946-960. PubMed ID: 29624843
    [Abstract] [Full Text] [Related]

  • 4. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
    Guo W, Sun YF, Shen MN, Ma XL, Wu J, Zhang CY, Zhou Y, Xu Y, Hu B, Zhang M, Wang G, Chen WQ, Guo L, Lu RQ, Zhou CH, Zhang X, Shi YH, Qiu SJ, Pan BS, Cao Y, Zhou J, Yang XR, Fan J.
    Clin Cancer Res; 2018 May 01; 24(9):2203-2213. PubMed ID: 29374055
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
    Zheng J, Cai J, Li H, Zeng K, He L, Fu H, Zhang J, Chen L, Yao J, Zhang Y, Yang Y.
    Cell Physiol Biochem; 2017 May 01; 44(3):967-981. PubMed ID: 29179180
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L, Zheng Z, Liu Y, Liu F, Li X, Wu Z.
    J Cancer Res Clin Oncol; 2023 Aug 01; 149(9):6035-6048. PubMed ID: 36633681
    [Abstract] [Full Text] [Related]

  • 9. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y, Wang B, Wu J, Zhang C, Zhou Y, Yang X, Zhou J, Guo W, Fan J.
    BMC Cancer; 2016 Jul 20; 16():506. PubMed ID: 27439521
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis.
    Fan JL, Yang YF, Yuan CH, Chen H, Wang FB.
    Cell Physiol Biochem; 2015 Jul 20; 37(2):629-40. PubMed ID: 26344495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
    Zhao L, Song J, Sun Y, Ju Q, Mu H, Dong X, Ding J, Liu Y, Wang X, Sun L, Wu J, Jiao Y, Lu S, Zhao X.
    Cancer Med; 2023 Jul 20; 12(13):13912-13927. PubMed ID: 37337648
    [Abstract] [Full Text] [Related]

  • 16. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
    Hao Q, Han Y, Xia W, Wang Q, Qian H.
    Can J Gastroenterol Hepatol; 2019 Jul 20; 2019():1684039. PubMed ID: 31187026
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.
    Ni HH, Yang XH, Yang CL, Zhang Q, Xu JX, Qi LN, Xiang BD.
    Biomed Res Int; 2022 Jul 20; 2022():7305953. PubMed ID: 35880030
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.